| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.087 | 0.008 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.009 |